LPL Financial’s Zevra Therapeutics ZVRA Stock Holding History
Bought
Maintained
Sold
Other funds holding ZVRA
LPL Financial's ZVRA Position: Q3 2026 in Review
LPL Financial increased its Zevra Therapeutics (ZVRA) stake by 29% in Q3 2026, buying an estimated $54.6K and bringing the position to 20,293 shares worth $223K. The position accounts for ﹤0.01% of the portfolio, ranked #5748.
LPL Financial first reported a position in ZVRA in Q1 2020 and has held it in 18 quarters since. The position peaked at $225K in Q2 2026. 175 funds tracked by Wall St. Rank hold ZVRA as of Q3 2026.
- LPL Financial held 20,293 shares of Zevra Therapeutics worth $223K as of Q3 2026.
- LPL Financial bought 4,608 Zevra Therapeutics shares in Q3 2026, an estimated $54.6K.
- Zevra Therapeutics made up ﹤0.01% of LPL Financial's portfolio in Q3 2026, its #5748 holding.
- LPL Financial first reported a position in Zevra Therapeutics in Q1 2020 and has held it in 18 quarters since.
- LPL Financial's Zevra Therapeutics position peaked at $225K in Q2 2026.
- 175 funds tracked by Wall St. Rank held Zevra Therapeutics as of Q3 2026.
Based on LPL Financial's 13F filing for Q3 2026, filed 6 Nov 2026.